Surgepays is trading at $0.14, down 5.57% in pre-market, with no clear catalyst identified.

  • No new company announcement or clear catalyst for the September 30 decline was identified.
  • On September 29, Nasdaq granted SurgePays another 180-day period, through March 22, 2027, to regain compliance with the $1.00 minimum bid requirement. Shares rose 11% to $0.15 on that news.
  • Broad market indicators were essentially flat; available evidence does not establish why shares are lower before the open.